Roche says its drugs reduce ventilator need for COVID-19 patients


Roche’s Actermra/Roactemra drugs reduces the likelihood patients with COVID-19 related pneumonia need mechanical ventilation, the company said on Friday.

Hospital patients taking the drug were 44% less likely to need ventilators or die, the company said, citing the results of its Empacta phase III study conducted in several countries including the United States.

Roche said it would share the results of its trial with health authorities, including the U.S. Food and Drug Administration. US SPREAD GOOD NEWS!

I run this site in my spare time and thoroughly enjoy giving you all positive news!  If you’ve enjoyed the site we’d love for you to help me share the good news far and wide, share us on Reddit, your Facebook or your Twitter and spread a little positivity around.


Our new page here is just what you need, with just good news, feel good stories unrelated to COVID.

By Justgivemepositivenews Team